-
EP3639812
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3639812
| EP3639812 - SPARINGLY-SOLUBLE COMPONENT SOLUBILIZED MICELLE AND SOLUTION CONTAINING SAME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.11.2023 Database last updated on 27.07.2024 | |
| Former | Examination is in progress Status updated on 24.02.2023 | ||
| Former | Request for examination was made Status updated on 20.03.2020 | ||
| Former | The international publication has been made Status updated on 08.12.2018 | Most recent event Tooltip | 03.11.2023 | Application deemed to be withdrawn | published on 06.12.2023 [2023/49] | Applicant(s) | For all designated states Teika Pharmaceutical Co., Ltd. 3-27 Arakawa 1-chome Toyama-shi, Toyama 930-0982 / JP | [2020/17] | Inventor(s) | 01 /
OKAKI, Toru c/o Teika Pharmaceutical Co. Ltd. 3-27 Arakawa 1-chome Toyama-shi Toyama 930-0982 / JP | [2020/17] | Representative(s) | Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstraße 2 80538 München / DE | [N/P] |
| Former [2020/17] | Teipel, Stephan, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | Application number, filing date | 18809663.0 | 01.06.2018 | [2020/17] | WO2018JP21129 | Priority number, date | JP20170110489 | 02.06.2017 Original published format: JP 2017110489 | [2020/17] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018221713 | Date: | 06.12.2018 | Language: | JA | [2018/49] | Type: | A1 Application with search report | No.: | EP3639812 | Date: | 22.04.2020 | Language: | EN | [2020/17] | Search report(s) | International search report - published on: | JP | 06.12.2018 | (Supplementary) European search report - dispatched on: | EP | 16.02.2021 | Classification | IPC: | A61K9/107, A61K31/192, A61K31/198, A61K31/405, A61K31/445, A61K31/4704, A61K31/575, A61K47/10, A61K47/26, A61K47/28, A61K47/32, A61K47/36, A61K47/38, A61K47/44, A61P1/04, A61P1/06, A61P1/08, A61P1/16, A61P11/02, A61P11/10, A61P17/00 | [2020/17] | CPC: |
A61K31/445 (EP,CN,KR);
A61K9/1075 (EP,CN,KR);
A61K9/107 (US);
A61K31/135 (KR);
A61K31/166 (EP);
A61K31/167 (EP,KR);
A61K31/192 (CN,KR);
A61K31/195 (KR);
A61K31/196 (EP,KR);
A61K31/197 (EP);
A61K31/198 (CN,KR);
A61K31/24 (EP);
A61K31/405 (CN,KR);
A61K31/4704 (CN,KR);
A61K31/542 (EP,KR);
A61K31/575 (CN,KR);
A61K45/06 (US);
A61K47/10 (EP,CN,KR);
A61K47/26 (EP,CN,KR);
A61K47/28 (EP,CN);
A61K47/32 (EP,CN,KR,US);
A61K47/34 (KR);
A61K47/36 (EP,CN);
A61K47/38 (EP,CN,KR);
A61K47/44 (EP,CN);
A61K9/0043 (EP,CN,KR);
A61K9/0048 (EP,CN,KR);
A61K9/08 (EP,CN);
A61K9/10 (CN);
A61P1/04 (EP);
A61P1/06 (EP);
A61P1/08 (EP);
A61P1/16 (EP);
A61P11/02 (EP,CN);
A61P11/10 (EP);
A61P17/00 (EP,CN);
A61P17/04 (CN);
A61P23/02 (EP);
A61P25/08 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/17] | Title | German: | GELÖSTE MIZELLE MIT SCHWACH LÖSLICHER KOMPONENTE UND LÖSUNG DAMIT | [2020/17] | English: | SPARINGLY-SOLUBLE COMPONENT SOLUBILIZED MICELLE AND SOLUTION CONTAINING SAME | [2020/17] | French: | MICELLE SOLUBILISÉE COMPRENANT UN COMPOSANT PEU SOLUBLE ET SOLUTION LA CONTENANT | [2020/17] | Entry into regional phase | 18.11.2019 | Translation filed | 18.11.2019 | National basic fee paid | 18.11.2019 | Search fee paid | 18.11.2019 | Designation fee(s) paid | 18.11.2019 | Examination fee paid | Examination procedure | 18.11.2019 | Examination requested [2020/17] | 14.09.2021 | Amendment by applicant (claims and/or description) | 27.02.2023 | Despatch of a communication from the examining division (Time limit: M04) | 11.07.2023 | Application deemed to be withdrawn, date of legal effect [2023/49] | 01.08.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/49] | Fees paid | Renewal fee | 31.03.2020 | Renewal fee patent year 03 | 22.06.2021 | Renewal fee patent year 04 | 27.06.2022 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.06.2023 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2009140429 (UNIV WASHINGTON [US], et al); | [X]WO2010023908 (UNIV SCHOOL ST MARIANNA [JP], et al); | [X]US2011021443 (LAMBERT GREGORY [FR], et al); | [X]US2012219600 (PERUMAL OMATHANU P [US], et al) | International search | [XY]JPH07109218 (TERUMO CORP); | [XY]US2001021390 (LAU JOHN R [US]); | [XY]JP2004161739 (LTT BIO PHARMA CO LTD); | [XY]WO2005018607 (AJINOMOTO KK [JP], et al); | [XY]JP2009510082 ; | [XY]JP2011241147 (NANO EGG:KK, et al); | by applicant | JPS538824B | JP2003519083 |